Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
about
Annotating Human P-Glycoprotein Bioassay DataScreening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interferencePurvalanol A, olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitroInhibition of efflux transporter-mediated fungicide resistance in Pyrenophora tritici-repentis by a derivative of 4'-hydroxyflavone and enhancement of fungicide activity.Microbial efflux pump inhibition: tactics and strategies.Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity.ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells.Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.Sucralose, a synthetic organochlorine sweetener: overview of biological issuesImprovement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancerIdentification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.ABC transporters, neural stem cells and neurogenesis--a different perspective.Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimersAdvancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.Nature and uses of fluorescent dyes for drug transporter studies.Renal Drug Transporters and Drug Interactions.P-gp activity and inhibition in the different regions of human intestine ex vivo.Single-vesicle estimation of ATP-binding cassette transporters in microfluidic channels.Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells.Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.Quantitative evaluation of isothiocyanates as substrates and inhibitors of P-glycoprotein.Reversing P-glycoprotein-mediated multidrug resistance in vitro by α-asarone and β-asarone, bioactive cis-trans isomers from Acorus tatarinowii.Three- and four-class classification models for P-glycoprotein inhibitors using counter-propagation neural networks.
P2860
Q27967903-9B5F1D64-2F05-40C1-AFC2-2B2BF6B6AC18Q28486133-4FF9AE57-4701-4282-B187-CB3A03FCDC6DQ28537944-7FA02D0E-F30C-4FEB-9027-471159955672Q30320212-E5247DDB-D469-4B2E-AF3B-43E0E2EC33EAQ34176211-4FBC8A33-5F1D-47B8-9FF0-E820097555BFQ34233691-3B481F5B-60E8-474F-A822-1737F92BC7A5Q34375459-B6BA693C-3098-40F5-8191-CDD4DF511E4DQ34613849-B83691B0-9205-426F-8403-8105326F66F0Q34657381-3B0F5823-3A40-40E8-BC32-9D39B170AFF7Q35090489-9BF993B5-7730-4B96-9790-F9674EE8F9D3Q35644350-761DF652-DD2B-43E0-82B3-38FE5F74C95DQ36646747-67ABDFAF-7A2F-4301-BE94-B26D5D3EBC3AQ37199454-1E56120D-E579-4D34-8084-CA4ADF472B37Q37507771-3284D155-9C49-4CCB-86ED-39E0976390D0Q38518912-3928816D-035F-40F5-8079-A20EBAB81D63Q39140289-80A54843-0F39-4A47-B46F-C7246F96FE57Q39272976-147FE2A0-8774-4718-BD23-321A975B2543Q39426133-E87A281C-1D68-4DDA-9838-149B571B9AB0Q39968960-80843A07-3FA9-4DA5-AF1F-ECC33E8BB670Q41958140-B11B290E-0D5C-4A6D-A212-62745DD15D25Q42831234-5D24A94C-EC02-48AB-84FC-029016E1D5A4Q42834309-D1624C02-537D-4A5A-BABB-B7B756752A9CQ44449148-766C2E17-E5EB-4224-A367-6A7E36BEA823Q50976814-C5797CAC-4DDB-41CA-8DC1-34EDA6640FB4
P2860
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Active transport of fluorescen ...... d interaction with inhibitors.
@en
type
label
Active transport of fluorescen ...... d interaction with inhibitors.
@en
prefLabel
Active transport of fluorescen ...... d interaction with inhibitors.
@en
P2093
P356
P1476
Active transport of fluorescen ...... d interaction with inhibitors.
@en
P2093
P304
P356
10.1006/BBRC.2001.6000
P577
2001-11-01T00:00:00Z